Life KFF Tracker: America First MOU Bilateral Global Health Agreements Strategic angle: This tracker provides up-to-date information on countries with signed bilateral MOU global health agreements with the U.S. Editorial Staff Apr 7
Life Novo Nordisk launches high-dose Wegovy Strategic angle: Insurers score Medicare Advantage wins, the obesity drug race continues, and other biotech news from The Readout. Editorial Staff Apr 7
Life Measles Elimination Status: What It Is and How the U.S. Could Lose It Strategic angle: This policy watch examines the United States’ measles elimination status and the potential threats to it. Editorial Staff Apr 7
Life States looking to regulate use of chatbots Strategic angle: In this edition of STAT Health Tech: UnitedHealth Group's big bet on AI to transform its operations, venture funding trends, and more. Editorial Staff Apr 7
Life Trump Budget’s ‘America First’ Drug Policy Proposals Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal. Editorial Staff Apr 7
Money Bill Gates interview about Jeffrey Epstein by House Oversight set for June 10 Strategic angle: Bill Gates is scheduled for an interview regarding his connections with Jeffrey Epstein, as part of a House Oversight inquiry. Editorial Staff Apr 7
Money Peter Schiff says an economic reckoning is nigh, 2008 will look like a ‘Sunday school picnic.’ Protect your nest egg now Strategic angle: Peter Schiff warns of an impending economic crisis, urging individuals to safeguard their investments. Editorial Staff Apr 7
Money Will Philip Morris International Overcome FDA Worries About Nicotine Pouch Use? Strategic angle: An analysis of Philip Morris International's challenges with FDA regulations regarding nicotine pouches. Editorial Staff Apr 7
Life 'Voorhees law' explains why the slower car often catches up Strategic angle: A new study reveals the phenomenon behind why faster cars can end up behind slower ones in traffic. Editorial Staff Apr 7
Life Many cancer patients don’t get genomic tests to guide treatment, study finds Strategic angle: Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival. Editorial Staff Apr 7